8-K
Current Report
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-18-018002
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading f8k122818_actinium.htm…